(a) Effective January 1, 1996, persons in the following list are allocated essential-use allowances or exemptions for quantities of a specific class I controlled substance for a specific essential-use (the Administrator reserves the right to revise the allocations based on future decisions of the Parties).
Table I - Essential Use Allowances for Calendar Year 2010
| (i) Metered Dose Inhalers (for oral inhalation) for Treatment of Asthma and Chronic Obstructive Pulmonary Disease | ||
|---|---|---|
| Company | Chemical | 2010 Quantity (metric tons) |
| Armstrong | CFC-11 or CFC-12 or CFC-114. | 30.0 |
(b) There is a global exemption for the production and import of class I controlled substances for essential laboratory and analytical uses, subject to the restrictions in appendix G of this subpart, and subject to the recordkeeping and reporting requirements at § 82.13(u) through (x). There is no amount specified for this exemption.
(c) Effective January 1, 2005, critical use allowances are apportioned as set forth in paragraph (c)(1) of this section for the exempted production and import of class I, Group VI controlled substances specifically for those approved critical uses listed in appendix L to this subpart for the applicable control period. Every kilogram of production and import in excess of the total number and type of unexpended critical use allowances held for a particular type of use constitutes a separate violation of this subpart.
(1) Allocated critical use allowances granted for specified control period.
| Company | 2016 Critical use allowances for pre-plant uses * (kilograms) |
2016 Critical use allowances for post-harvest uses * (kilograms) |
|---|---|---|
| Great Lakes Chemical Corp. A Chemtura Company | 84,222 | 1,179 |
| Albemarle Corp. | 34,634 | 485 |
| ICL-IP America | 19,140 | 268 |
| TriCal, Inc. | 596 | 8 |
| Total | 138,592 | 1,939 |
(2) [Reserved]
[69 FR 77003, Dec. 23, 2004]